Navigation Links
TetraLogic Closes $6 Million Series C-1 Investment with Nextech Invest Ltd.
Date:5/24/2011

y apoptosis.

About TetraLogic Pharmaceuticals

TetraLogic Pharmaceuticals is a privately held biopharmaceutical company that focuses on the discovery and development of Smac mimetics, small molecule drugs that mimic Smac (Second mitochondrial-derived activator of caspases) for the treatment of cancers. The company's investors include Clarus Ventures, HealthCare Ventures, Quaker BioVentures, Novitas Capital, Hatteras Venture Partners, Pfizer Ventures, Latterell Venture Partners, the Vertical Group, Amgen Ventures, Kammerer Associates, and Andrew Pecora, TetraLogic's chairman of the board and former chairman of the John Theurer Cancer Center at Hackensack University Medical Center, and George McLendon, a founding scientist, chairman of TetraLogic's scientific advisory board, and provost of Rice University. For additional information, please refer to the company's Web site at www.tetralogicpharma.com.

About Nextech Invest Ltd.

Nextech Invest is a global investment manager founded 1998 and located in Zurich, Switzerland. With its unique oncology-focused funds, Nextech Invest is a dedicated investor in leading oncology companies developing cancer drugs and diagnostics. Nextech Invest benefits from the support of an active and committed Scientific Advisory Board of highly influential oncology advisors, chaired by David Livingston, MD, deputy director at the Dana-Farber Cancer Institute/Harvard Cancer Center. For more information, please visit www.nextechinvest.com.

Media Contacts:

Russo Partners LLC
Tony Russo, Ph.D., or Andreas Marathovouniotis
212-845-4251 or 212-845-5235
tony.russo@russopartnersllc.com
andreas.marathis@russopartnersllc.com

TetraLogic Pharmaceuticals'/>"/>

SOURCE TetraLogic Pharmaceuticals
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. TetraLogic Closes $23 Million Second Tranche of Series C Financing
2. Xlumena, Inc. Closes $7M Series B Venture Financing Round
3. CoDa Therapeutics Closes $19 Million Series B Financing Round
4. Benvenue Medical Closes $35.5 Million Series C Financing
5. PixelOptics Closes $45 Million Financing
6. AnaBios Corporation Closes Series A Financing
7. OncoSec Medical Closes Purchase and License Agreement for Tumor Therapy Technology with Inovio Pharmaceuticals
8. OncoSec Medical Closes $1.1M Financing
9. Patient Safety Technologies, Inc. Closes $7.1 Million Common Stock Offering
10. BridgePoint Medical Closes $9.1 Million Series C Financing
11. Palatin Technologies, Inc. Closes $23 Million Public Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015 ... für kongestive Herzinsuffizienz (CHF) in seiner ersten ...     Die israelische ... Herzüberwachungssystem für Patienten mit kongestiver Herzinsuffizienz (CHF) ... ein Finanzierungsvorhaben über 5 Mio. USD abgeschlossen ...
(Date:2/27/2015)... Feb. 27, 2015  Two mass spectrometry ... applications as their effectiveness is established, according ...  Kalorama Information says that while mass spectrometry ... powerful tool in proteomic biomarker discovery and ... its traditional techniques has struggled to elucidate ...
(Date:2/26/2015)... , Feb. 26, 2015  AbbVie (NYSE: ... of studies in its neuroscience and oncology development ... 67 th American Academy of Neurology annual ... from April 18-25. The accepted abstracts feature results ... addition to investigational treatments in AbbVie,s pipeline. Presentations ...
Breaking Medicine Technology:Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 2Report: "Softer" Mass Spec Techniques Gaining Popularity in Biomarker Discovery 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 2AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 3AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 4AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 5AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 6AbbVie's Ongoing Research in Neuroscience and Oncology will be Featured at the 2015 American Academy of Neurology Annual Meeting 7
... Shire plc (LSE: SHP, Nasdaq: SHPGY ), ... a 5-aminosalicylic acid (5-ASA) persistency analysis entitled, "Twelve-month Persistence ... Database," at Digestive Disease Week, on May 31, 2009. ... continuing patients, 20 percent of Lialda patients were continually ...
... Trubion Pharmaceuticals, Inc. (Nasdaq: TRBN ... 1 safety and efficacy results following administration of ... with high-risk genomic factors and relapsed or refractory ... proprietary anti-CD37 Small Modular ImmunoPharmaceutical (SMIP(TM)) product candidate. ...
Cached Medicine Technology:Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week 2Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week 3Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week 4Shire Presented Results of a New Database Analysis on Lialda(R) (Mesalamine) and Other 5-ASAs for Ulcerative Colitis at Digestive Disease Week 5Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL) 2Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL) 3Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL) 4Trubion Announces Positive Data From a Phase 1 / 2 Study of TRU-016 for the Treatment of Chronic Lymphocytic Leukemia (CLL) 5
(Date:2/27/2015)... February 27, 2015 On February 24 2015, ... Liquid Botox ,” that details the development of RT001, ... working its way through FDA trials. For those afraid of ... is very attractive. Of course, if the drug ultimately gets ... a physician’s office. (see: goo.gl/PQvQwk) , “As the article notes, ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 The winter season ... growth and expansion. When mold grows, it can be harmful ... sure to avoid the consequences of mold growth with the ... Island, is offering tips on the best ways to prevent ... season, which makes perfect conditions for mold to thrive. Mold ...
(Date:2/27/2015)... February 27, 2015 Florida Hospital North ... Guidelines - Stroke Gold Plus hospital. In order to ... or higher adherence to all Get With The Guidelines ... consecutive 12-month intervals and achieved 75-percent or higher compliance ... Stroke Quality Measures. These are reporting initiatives to measure ...
(Date:2/27/2015)... The Nashville periodontist office, ... for rising freshmen undergraduate students. , The Advanced Institute ... in many periodontal procedures such as dental implants ... disease . In honor of their 25th anniversary, AIOH ... rising freshmen undergraduate students. , Students interested in ...
(Date:2/27/2015)... Raton, FL (PRWEB) February 27, 2015 ... diagnostic testing company that provides vascular, echocardiogram and ... proud to be the preferred diagnostic testing provider ... University, a coeducational public liberal arts university in ... by the Wimbledon U collegiate division, ...
Breaking Medicine News(10 mins):Health News:Is Topical Botox the Next Big Thing? 2Health News:Enviro-Test Offers Tips for Winter Mold Prevention 2Health News:Florida Hospital North Pinellas Receives Get With The Guidelines - Stroke Gold Plus Quality Achievement Award 2Health News:Nashville Periodontist Office AIOH Announces 2015 Scholarship 2Health News:Georgia College Ensures Student-Athletes Are Heart Smart Team Strong; Teams up with Wimbledon Health Partners to Offer Diagnostic Testing 2Health News:Georgia College Ensures Student-Athletes Are Heart Smart Team Strong; Teams up with Wimbledon Health Partners to Offer Diagnostic Testing 3
... could lose brain function earlier than is noticeably detectable, ... Physicians need a method to assess these sensitive changes ... tests. Penn State College of Medicine researchers created ... in judgment and problem-solving in ALS patients. FTD is ...
... June 22 (HealthDay News) -- Heart damage caused by heavy ... a new study. Researchers assessed the heart health of ... drug rehabilitation program 48 hours after they last used cocaine. ... years and consumed about 5.5 grams of cocaine per day. ...
... , TUESDAY, June 21 (HealthDay News) -- High doses of ... a downside. A new meta-analysis finds that intensive doses ... of being diagnosed with type 2 diabetes compared with moderate ... revealed a lower incidence of heart attacks, stroke and death, ...
... By Alan Mozes HealthDay Reporter , TUESDAY, ... play date, American parents may want to ask if there ... The reason: almost 2 million American homes with kids contain ... each year from unintentional shootings. That,s why the Center ...
... HealthDay Reporter , TUESDAY, June 21 (HealthDay News) ... and psoriasis may help patients with these autoimmune disorders ... New research found that a particular class of disease-modifying ... inhibitors and the antimalarial drug hydroxychloroquine can reduce ...
... By Alan Mozes HealthDay Reporter , TUESDAY, June ... research suggests that repeated bouts of unemployment don,t affect everyone ... people who are consistently successful in finding new work after ... so-called "serial joblessness" than are those who lose a job ...
Cached Medicine News:Health News:Brief exam diagnoses cognitive impairment in ALS patients 2Health News:Cocaine-Related Heart Damage May Be 'Silent' 2Health News:High-Dose Statins May Increase Diabetes Risk 2Health News:High-Dose Statins May Increase Diabetes Risk 3Health News:Making Sure Child's Play Doesn't Turn Into Gunplay 2Health News:Making Sure Child's Play Doesn't Turn Into Gunplay 3Health News:Making Sure Child's Play Doesn't Turn Into Gunplay 4Health News:Some Drugs for Rheumatoid Arthritis, Psoriasis May Cut Diabetes Risk 2Health News:Some Drugs for Rheumatoid Arthritis, Psoriasis May Cut Diabetes Risk 3Health News:Unemployment May Hit Some Harder Than Others 2Health News:Unemployment May Hit Some Harder Than Others 3Health News:Unemployment May Hit Some Harder Than Others 4
For the quantitative determination of total glucose in serum....
Intended for the quantitative determination of glucose in biological fluids. Reaction: endpoint. Wavelength: 340 nm. Linearity: 800 mg/dL (44.4 mmol/L). Single vial, dry powder reagent....
Inorganic phosphorus (UV method) reagent is for the quantitative determination of inorganic phosphorus in human serum....
For the quantitative determination of Inorganic Phosphorus in serum. Linearity: 12.0 mg/dl....
Medicine Products: